MENUNews Archive
Date: 07/29/2025
The University of Michigan Health Rogel Cancer Center was recognized as the No. 1 cancer program in Michigan and No. 32 in the nation by U.S. News & World Report Best Hospital rankings for 2025-2026. Rogel was the only cancer program in the state to be ranked.
Date: 07/16/2025
Costas Lyssiotis, Ph.D., co-director of the Rogel and Blondy Center for Pancreatic Cancer at the Rogel Cancer Center, was one of six researchers to receive inaugural grants from the Stephenson Global Pancreatic Cancer Research Institute and its partner, City of Hope. The grants, totaling $5.25 million, support high-impact research aimed at transforming the understanding, early detection and treatment of pancreatic cancer.
Date: 07/15/2025
The University of Michigan Rogel Cancer Center has named breast oncologist N. Lynn Henry, M.D., Ph.D., as associate director for community outreach and engagement. As associate director, Henry will partner with Rogel faculty and staff to develop research and interventions to address the cancer burden within the state.
Date: 06/16/2025
The 2025 American Society of Clinical Oncology Annual (ASCO) Meeting was held in Chicago, Illinois, May 30-June 3. Many Rogel researchers participated in presentations, poster sessions and panel discussions before an audience of cancer researchers from around the globe. Read on for the highlights.
Date: 06/06/2025
Researchers from the University of Michigan received a $6 million center grant from the National Institutes of Health to establish the new National Center for Biomedical Imaging and Bioengineering. The center will be dedicated to microsystems-based imaging systems.
Date: 06/02/2025
Rogel Cancer Center receives $50M gift from Richard and Susan Rogel to aim to revolutionize how the world detects, treats, and ultimately cures pancreatic cancer.
Date: 06/02/2025
Patients with cancer-linked variants in ATM, CHEK2 or PALB2 genes do not have a greater risk of dying from their disease, research finds
Date: 06/02/2025
Bazedoxifene and conjugated estrogens reversed obesity-associated changes, supporting their use in patients
Date: 06/02/2025
In combination with radiation therapy, treatment vastly improved mouse survival
Date: 06/02/2025
Simultaneous targeting of PIKfyve and KRAS-MAPK eliminates tumors in preclinical human and mouse models